Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserving Access to Orphan Drugs Act of 2013
Client: NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) · Firm: NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
Patients' Access to Treatment (HR 460) FDA Safety Over Sequestration Act (HR 2725/S 1413) Preserving Access to Orphan Drugs Act (S 1128/HR 2315) Medical Foods for Inborn Errors of Metabolism
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) · Firm: NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2013 · third_quarter · Q3
Patients' Access to Treatment (HR 460) FDA Safety Over Sequestration Act (HR 2725/S 1413) Preserving Access to Orphan Drugs Act (S 1128/HR 2315) Medical Foods for Inborn Errors of Metabolism
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2013 · second_quarter · Q2
Source: Senate LDA
Patients' Access to Treatment (HR 460) FDA Safety Over Sequestration Act (HR 2725/S 1413) Preserving Access to Orphan Drugs Act (S 1128/HR 2315) Medical Foods for Inborn Errors of Metabolism
Patients' Access to Treatments Act of 2013
Client: NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) · Firm: NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
Patients' Access to Treatment (HR 460) FDA Safety Over Sequestration Act (HR 2725/S 1413) Preserving Access to Orphan Drugs Act (S 1128/HR 2315) Medical Foods for Inborn Errors of Metabolism
Preserving Access to Orphan Drugs Act of 2013
Client: NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) · Firm: NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
Patients' Access to Treatment (HR 460) FDA Safety Over Sequestration Act (HR 2725/S 1413) Preserving Access to Orphan Drugs Act (S 1128/HR 2315) Medical Foods for Inborn Errors of Metabolism
FDA User Fee Protection Act
Client: NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) · Firm: NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
Patients' Access to Treatment (HR 460) FDA Safety Over Sequestration Act (HR 2725/S 1413) Preserving Access to Orphan Drugs Act (S 1128/HR 2315) Medical Foods for Inborn Errors of Metabolism
Creating Hope Act of 2010
Client: NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) · Firm: NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
FDA Appropriations Rare and Neglected Diseases Caucus Creating Hope Act S3697 Prescription Drug User Fee Act Reauthorization Medical Devices User Fee Act Reauthorization
Implementation of the FDA Safety & Innovation Act SSA Compassionate Allowances Program Federal Budget Support for Health Research, Innovation & Consumer Protection Patient Choice Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2013 · first_quarter · Q1
Implementation of the FDA Safety & Innovation Act SSA Compassionate Allowances Program Federal Budget Support for Health Research, Innovation, & Consumer Protection
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2012 · fourth_quarter · Q4
Food and Drug Administration Safety and Innovation Act Reauthorization of the Prescription Drug User Fee & Medical Device User Fee Acts
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2012 · third_quarter · Q3
Food and Drug Administration Safety and Innovation Act Reauthorization of the Prescription Drug User Fee & Medical Device User Fee Acts
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2012 · third_quarter · Q3
Reauthorization of the Prescription Drug User Fee & Medical Device User Fee Acts Food and Drug Administration Safety and Innovation Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2012 · first_quarter · 1A
Rare Disease Caucus Reauthorization of the Prescription Drug User Fee & Medical Device User Fee Acts Patient Access to Medical Innovation Act Unlocking Lifesaving Treatments for Rare Diseases Act or ULTRA Humanitarian Device Reform Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2012 · first_quarter · Q1
Rare Disease Caucus Humanitarian Device Reform Act Reauthorization of the Prescriptin Drug User Fee & Medical Device User Fee Acts Patient Access to Medical Innovation Act Unlocking Lifesaving Treatments for Rare Diseases Act or ULTRA
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2011 · fourth_quarter · Q4
Rare Disease Caucus Humanitarian Device Reform Act Prescription Drug User Fee Act Medical Device User Fee Act Patient Access to Medical Innovation Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2011 · third_quarter · Q3
Compassionate Allowances Initiative Medical Foods Equity Act Medical Devices Rare Disease Caucus FDA Appropriations Creating Hope Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2011 · second_quarter · Q2
Modern Cures Act Rare Disease Caucus Compassionate Allowances Medicla Devices FDa Appropriations
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2011 · first_quarter · Q1
PDUFA Rare Disease Caucus
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2010 · fourth_quarter · Q4
Rare & Neglected Disease Caucus PDUFA
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD) via NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)
2010 · third_quarter · Q3
FDA Appropriations Rare and Neglected Diseases Caucus Creating Hope Act S3697 Prescription Drug User Fee Act Reauthorization Medical Devices User Fee Act Reauthorization
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE